Luke Hughes-Davies

Methods used for multiparameter assay cost-effectiveness literature review

Peter Hall, Andrea Marshall, Nigel Stallard, 2016 .

Additional details of the multiparameter tests

Peter Hall, Andrea Marshall, Nigel Stallard, 2016 .

EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer

Luke Hughes-Davies, Carlos Caldas, David S Yu, 2003, Cell.

The Tudor domain 'Royal Family': Tudor, plant Agenet, Chromo, PWWP and MBT domains.

Sebastian Maurer-Stroh, Frank Eisenhaber, Luke Hughes-Davies, 2003, Trends in biochemical sciences.

A functionally significant cross-talk between androgen receptor and ErbB2 pathways in estrogen receptor negative breast cancer.

Luke Hughes-Davies, A. Naderi, L. Hughes-Davies, 2008, Neoplasia.

OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer.

John M S Bartlett, Christopher McCabe, Nigel Stallard, 2016, Health technology assessment.

Amplification of the BRCA2 Pathway Gene EMSY in Sporadic Breast Cancer Is Related to Negative Outcome

Luke Hughes-Davies, Charles Theillet, Tony Kouzarides, 2004, Clinical Cancer Research.

DNA methyltransferase Dnmt1 associates with histone deacetylase activity

Luke Hughes-Davies, François Fuks, Tony Kouzarides, 2000, Nature Genetics.

Transcriptional activation functions in BRCA2

Luke Hughes-Davies, Tony Kouzarides, B. Ponder, 1997, Nature.